PPAR activation and progression of subclinical atherosclerosis in insulin requiring type 2 diabetes mellitus

被引：0
|
作者：
Hodis, HN [1 ]
Buchanan, TA [1 ]
Li, YJ [1 ]
Torres, M [1 ]
Mack, WJ [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA 90089 USA
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3349
引用
收藏
页码：741 / 741
页数：1
相关论文
共 50 条
  • [31] Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets
    Plutzky, J
    Viberti, G
    Haffner, S
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2002, 16 (06) : 401 - 415
  • [32] Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus
    Salvado, Laia
    Serrano-Marco, Lucia
    Barroso, Emma
    Palomer, Xavier
    Vazquez-Carrera, Manuel
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (02) : 209 - 223
  • [33] Subclinical atherosclerosis in type 1 diabetes
    Abdelghaffar, Shereen
    Hafez, Mona
    Salah, Nermeen
    El-Amir, Mona
    El-Hadidy, Amr
    Elmougy, Fatma
    Abdelhamid, Fayza
    Mandour, Iman
    Ghaly, Isis
    HORMONE RESEARCH, 2008, 70 : 55 - 55
  • [34] Low-dose rosiglitazone in patients with type 2 diabetes mellitus requiring insulin therapy
    Lopez, Cesar A.
    Kanna, Balavenkatesh
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (05) : 548 - 548
  • [35] Intercellular adhesion molecule-1 is a surrogate biomarker for subclinical atherosclerosis in Type 2 diabetes mellitus
    Sasikala, Thallapaneni
    Manohar, Suchitra M.
    Bitla, Aparna R. R.
    Sarala, S.
    Vaikkakara, Suresh
    BIOMARKERS IN MEDICINE, 2021, 15 (02) : 121 - 132
  • [36] Serum uric acid is associated with micro albuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus
    Fukui, Michiaki
    Tanak, Muhei
    Shiraishi, Emi
    Harusato, Ichiko
    Hosoda, Hiroko
    Asano, Mai
    Kadono, Mayuko
    Hasegawa, Goji
    Yoshikawa, Toshikazu
    Nakamura, Naoto
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (05): : 625 - 629
  • [37] The Relationship between Bone Morphogenic Protein 4 and Subclinical Atherosclerosis in Patients with Type 2 Diabetes Mellitus
    Son, Jang Won
    Jang, Eun Hee
    Kim, Su Yoen
    Kim, Mee Kyoung
    Baek, Ki Hyun
    Song, Ki Ho
    Yoon, Kun Ho
    Cha, Bong Yun
    Son, Ho Young
    Lee, Kwang Woo
    Kwon, Hyuk Sang
    DIABETES, 2010, 59 : A220 - A220
  • [38] TRIGLYCERIDE GLUCOSE INDEX IS ASSOCIATED WITH SUBCLINICAL ATHEROSCLEROSIS AND SUBCLINICAL MYOCARDIAL DYSFUNCTION IN PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS
    Ustabas, Sena H.
    Altunoglu, Esma G.
    Karabag, Turgut
    DIABETES MELLITUS, 2024, 27 (03): : 224 - 232
  • [39] Insulin resistance and atherosclerosis in diabetes mellitus
    Wollesen, F
    Berglund, L
    Berne, C
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (08): : 941 - 948
  • [40] Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes
    Xiang, AH
    Peters, RK
    Kjos, SL
    Ochoa, C
    Marroquin, A
    Goico, J
    Tan, S
    Wang, CW
    Azen, SP
    Liu, CR
    Liu, CH
    Hodis, HN
    Buchanan, TA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04): : 1986 - 1991
12345